Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Virokine Therapeutics Logo
Virokine Therapeutics Growth Score
32
CB Rank
184378
Heat Score
61
Virokine Therapeutics is a Biotechnology company.
Founded
obfuscation
PrivateDebt Financing London, England, United Kingdom1-10 virokine.com
Biotechnology
Overview

Virokine Therapeutics
Total Funding
obfuscation
Growth Score
32
Heat Score
61

Total Funding
obfuscation
obfuscation
Debt Financing raised
obfuscation
Growth Score32
-2 pts
in past quarter
Heat Score 61
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Virokine Therapeutics

CB Rank
184378
Virokine Therapeutics is a Biotechnology company.
Founded
obfuscation
PrivateDebt Financing London, England, United Kingdom1-10 virokine.com
Biotechnology

Funding Rounds

Debt Financing
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Virokine Therapeutics Ltd
Operating Status Active
Company Type For Profit
Founders  Ursula Gompels
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

HSV-2 DNA Vaccine
A gene-based vaccine designed to provide both preventative and therapeutic protection against herpes simplex virus 2 (HSV-2), showing high efficacy in preclinical trials.
Virokine Immune Therapeutic (VIT)
A proprietary biotechnology that inhibits chemokine receptors on T regulatory immune cells to enhance immune response, useful for vaccines.

Research & Development

Virokine Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Virokine Therapeutics Logo
Debt Financing - Virokine Therapeutics
1
obfuscation
— Debt Financing

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Apr 1, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$205.5KThis year, Virokine Therapeutics is projected to spend $205.5K on IT, according to Aberdeen.

Active Website Tech Count

21Virokine Therapeutics is actively using 21 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

2The intellectual property of Virokine Therapeutics includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Virokine Therapeutics's headquarters? Virokine Therapeutics is located in London, England, United Kingdom.Who invested in Virokine Therapeutics? Virokine Therapeutics is funded by North Carolina Biotechnology Center.When was the last funding round for Virokine Therapeutics? Virokine Therapeutics closed its last funding round on
obfuscation
from a Debt Financing round.Who are Virokine Therapeutics's competitors? Alternatives and possible competitors to Virokine Therapeutics may include Moderna, Vir Biotechnology, and  Valneva.How much funding has Virokine Therapeutics raised to date? Virokine Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|